Regeneron Pharmaceuticals

Get in the Ideas Business.
At Regeneron we believe that when the right idea finds the right team, powerful change is possible.
As we work together to discover, invent, and develop biopharmaceutical medicines, we’re creating whole new ways of thinking about science, manufacturing and commercialization. And whole new ways of thinking about health.
So connect with us. Tell us about you. Learn more about our life-changing medicines. And join us, as we build a future we believe in.

Tarrytown, US
4,300 (est)+48%
Regeneron Pharmaceuticals was founded in 1988 and is headquartered in Tarrytown, US

Regeneron Pharmaceuticals Locations

Tarrytown, US
Dublin, IE
Limerick, IE
Bernards, US
Rensselaer, US

Regeneron Pharmaceuticals Metrics

Regeneron Pharmaceuticals Summary

Market capitalization

$38.1 B

Closing share price

Regeneron Pharmaceuticals's current market capitalization is $38.1 B.

Regeneron Pharmaceuticals Financials

Regeneron Pharmaceuticals's revenue is $4.1 B in FY, 2015 which is 45.55% increase from the previous period.
FY, 2013FY, 2014FY, 2015


$2.1 B$2.82 B$4.1 B

Gross profit

$1.99 B$2.69 B$3.86 B

Operating income

$760 M$838 M$1.25 B

Operating expense total

$1.23 B$1.85 B$2.61 B

Net Income

$424 M$348 M$636 M

Operating cash flow

$305 M$113 M$160 M

    Regeneron Pharmaceuticals Market Value History

    Regeneron Pharmaceuticals Online Presence

    Regeneron Pharmaceuticals News

    Regeneron Pharmaceuticals Company Life

    You may also be interested in